Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
52
ADXN Quote, Financials, Valuation and Earnings
Last price:
$8.38
Seasonality move
:
-15.39%
Day range:
$8.05 - $8.99
52-week range:
$6.51 - $12.05
Dividend yield:
0%
P/E ratio:
0.77x
P/S ratio:
38.58x
P/B ratio:
0.92x
Volume:
11.4K
Avg. volume:
7.2K
1-year change:
12.8%
Market cap:
$8.3M
Revenue:
$465.6K
EPS (TTM):
$5.14
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Addex Therapeutics Ltd. has 233.7% upside to fair value with a price target of $30.00 per share.
ADXN vs. S&P 500
-
Over the past 5 trading days, Addex Therapeutics Ltd. has overperformed the S&P 500 by 23.14% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Addex Therapeutics Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Addex Therapeutics Ltd. revenues have been falling on a year-over-year basis for 8 quarters in a row. In the most recent quarter Addex Therapeutics Ltd. reported revenues of $62.3K.
Earnings Growth
-
Addex Therapeutics Ltd. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Addex Therapeutics Ltd. reported earnings per share of -$1.33.
Enterprise value:
5.5M
EV / Invested capital:
--
Price / LTM sales:
38.58x
EV / EBIT:
--
EV / Revenue:
28.60x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
-3.11x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
62.62%
Net Income Margin (TTM):
-838.93%
Return On Equity:
91.08%
Return On Invested Capital:
91.08%
Operating Margin:
-1155.7%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2024-06-30 | 2025-06-30 | |
| Income Statement | ||||||
| Revenue | $2.3M | $942.3K | $192.1K | $127.4K | $44K | |
| Gross Profit | -- | -- | $41.5K | -- | $41.5K | |
| Operating Income | -$8.8M | -$3.6M | -$2.8M | -$994.3K | -$887.3K | |
| EBITDA | -$8.6M | -$3.1M | -$2.7M | -$870K | -$884.8K | |
| Diluted EPS | -$28.33 | -$3.17 | -$8.49 | $10.17 | -$2.66 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $22.7M | $11.4M | $9.7M | $5.2M | $3.3M | |
| Total Assets | $23.3M | $11.9M | $10M | $15.2M | $10.7M | |
| Current Liabilities | $4M | $4.5M | $3M | $1M | $1.4M | |
| Total Liabilities | $5.5M | $4.7M | $3.2M | $1.2M | $1.6M | |
| Total Equity | $17.7M | $7.2M | $6.8M | $14.1M | $9.1M | |
| Total Debt | $454.5K | $352K | $259.9K | $35.8K | $48.2K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2024-06-30 | 2025-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$11.4M | -$8.7M | -$1.8M | -$3M | -$509.6K | |
| Cash From Investing | -$2.3K | $5.2M | -$778.7K | $5.2M | -$850.3K | |
| Cash From Financing | $10.2M | -$168K | $865.1K | -$68.7K | $753.6K | |
| Free Cash Flow | -$11.4M | -$8.7M | -$1.8M | -$3M | -$509.6K | |
ADXN
Sector
Market Cap
$8.3M
$28.4M
Price % of 52-Week High
74.61%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-12.49%
-1.32%
1-Year Price Total Return
12.8%
-22.19%
Beta (5-Year)
1.573
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$7.90
200-day SMA
Buy
Level
$8.36
Bollinger Bands (100)
Buy
Level
7.91 - 9.37
Chaikin Money Flow
Sell
Level
-3.7M
20-day SMA
Buy
Level
$8.33
Relative Strength Index (RSI14)
Buy
Level
55.46
ADX Line
Buy
Level
23.09
Williams %R
Neutral
Level
-20.2793
50-day SMA
Buy
Level
$8.85
MACD (12, 26)
Sell
Level
-0.22
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Neutral
Level
27M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-42.8213)
Sell
CA Score
(Annual)
Level (-1.177)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (9.6854)
Sell
Piotroski F Score
(Annual)
Level (3)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
Stock Forecast FAQ
In the current month, ADXN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ADXN average analyst price target in the past 3 months is $30.00.
-
Where Will Addex Therapeutics Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Addex Therapeutics Ltd. share price will rise to $30.00 per share over the next 12 months.
-
What Do Analysts Say About Addex Therapeutics Ltd.?
Analysts are divided on their view about Addex Therapeutics Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Addex Therapeutics Ltd. is a Sell and believe this share price will drop from its current level to $30.00.
-
What Is Addex Therapeutics Ltd.'s Price Target?
The price target for Addex Therapeutics Ltd. over the next 1-year time period is forecast to be $30.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ADXN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Addex Therapeutics Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ADXN?
You can purchase shares of Addex Therapeutics Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Addex Therapeutics Ltd. shares.
-
What Is The Addex Therapeutics Ltd. Share Price Today?
Addex Therapeutics Ltd. was last trading at $8.38 per share. This represents the most recent stock quote for Addex Therapeutics Ltd.. Yesterday, Addex Therapeutics Ltd. closed at $8.99 per share.
-
How To Buy Addex Therapeutics Ltd. Stock Online?
In order to purchase Addex Therapeutics Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get ADXN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ADXN
Sector
P/E ratio
0.77x
23.66x
PEG ratio
-0.01x
-0.01x
P/B ratio
0.92x
1.84x
Price / LTM sales
38.58x
1.60x
Growth Metrics
ADXN
Sector
Revenue growth
-83.22%
4.85%
Earnings growth
--
11.15%
Revenue (5-year growth)
-30.4%
6.45%
Earnings forecast
--
-$0.20
Profitability
ADXN
Sector
Profitability FY 2024
--
$3.6M
Return on invested capital
91.08%
-30.98%
Return on assets
62.62%
-27.62%
Return on equity
91.08%
-36.69%
Earnings Date
Last Earnings Date
Dec
4
Next Earnings Date
Dec
4
Estimated Next Earnings Date
Mar
5
Balance Sheet
ADXN
Sector
Total cash
$3.2M
$27.2M
Short term investments
$7.2K
$25.7M
Total assets
$11.8M
$79.9M
Long term debt
--
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
65
Is AAPL Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
